Evaluation of Anti Dandruff Efficacy of Test products on Healthy Human Subjects based on Half Head Application Design.

ITC LIMITED ITC Life Sciences and Technology Centre0 个研究点目标入组 47 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1 Healthy Indian / Asian male and female subjects in the age group of 20-45 yrs.
•2Subjects who are willing to give signed informed consent and who consent to abide by the study protocol and restrictions for the entire study duration.
•3 Subjects with hair of sufficient length that allows parting of scalp hair into clear sections for scalp examination.
•4 Subjects with moderate to severe scalp dandruff score (with dandruff on both sides of the scalp).
•5 Subjects with moderate to severe scalp itch score (DermatologistÃ¢â?¬•s scoring based on subjectÃ¢â?¬•s feedback).
•6 Subjects who have not participated in a similar investigation in the past four weeks.
•7 Subjects who are not sensitive to the ingredients of the test product (As disclosed by the subjects or as observed during the Skin sensitivity test).

•Subjects with a known history or present condition of allergic response to any shampoo or conditioner.
•1 Subjects having communicable skin/scalp infections or other skin disease (e.g. psoriasis, atomic dermatitis or other cutaneous manifestations), which could interfere with the test results as diagnosed by Dermatologist.
•2 Subjects with severe hair fall due to endocrine disorders as diagnosed by dermatologist or revealed through oral interview.
•3 Subjects on medications (steroids, antihistamines, antimicrobials), which would compromise the study results (Subjects inputs).
•4 Subjects with very short hair as in those sporting Crew cut or near tonsured scalps.
•5 Female subjects who are pregnant (determined by Urine pregnancy test), lactating or planning pregnancy during the course of the study (Subjects inputs).
•6 Subjects with signs and symptoms of systemic and / or chronic illness (As diagnosed by Dermatologist)
•7 Subjects who are undergoing therapy for dandruff (Subjects inputs).

发起方

ITC LIMITED ITC Life Sciences and Technology Centre